NCT06180083View on ClinicalTrials.gov

Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 24, 2023

Primary Completion Date

April 26, 2023

Study Completion Date

July 5, 2023

Conditions
Seasonal Allergic RhinitisPerennial Allergic Rhinitis
Interventions
DRUG

Azelastine Hydrochloride/ Fluticasone propionate nasal spray

A single dose \[four sprays (two sprays in each nostril)\] of Azelastine HCL/ Fluticasone Propionate 137 mcg/50 mcg Nasal Spray

DRUG

'DYMISTA' NASAL SPRAY

A single dose \[four sprays (two sprays in each nostril)\] of 'DYMISTA' (AZELASTINE HYDROCHLORIDE/ FLUTICASONE PROPIONATE) NASAL SPRAY 137 Microgram/50 Microgram

Trial Locations (1)

382210

Cliantha Research Limited, Ahmedabad

All Listed Sponsors
lead

Humanis Saglık Anonim Sirketi

INDUSTRY